All insights
Funding·5 min read·

Hippocratic AI Raises $141M Series B to Deploy Safety-Focused Healthcare AI Agents

Hippocratic AI, founded by healthcare and AI leaders, secures $141M Series B led by Andreessen Horowitz to deploy AI agents for patient communication, care coordination, and chronic disease management. Platform emphasizes safety testing and clinical validation.

World Health AI Summit

<div class="prose prose-invert max-w-none"> <p class="text-lg text-gray-100 leading-relaxed"> <strong class="text-white">Hippocratic AI</strong>, a healthcare AI startup focused on safety-certified AI agents, announced a <strong class="text-white">$141 million Series B</strong> led by <strong class="text-white">Andreessen Horowitz</strong>. The company is developing conversational AI agents for <strong class="text-white">patient communication, appointment scheduling, medication adherence,</strong> and <strong class="text-white">chronic disease management</strong>. </p> <p class="text-lg text-gray-100 leading-relaxed"> Founded by former executives from Google Health, Epic Systems, and Johns Hopkins Medicine, Hippocratic AI differentiates through <strong class="text-white">rigorous safety testing protocols</strong> developed in collaboration with academic medical centers. The company has conducted <strong class="text-white">50,000+ safety evaluations</strong> comparing its AI agents to human healthcare workers across clinical scenarios. </p> <p class="text-lg text-gray-100 leading-relaxed"> Platform capabilities include: </p> <ul class="text-lg text-gray-100 space-y-2"> <li><strong class="text-white">Chronic care management:</strong> Proactive outreach to diabetes, hypertension, and heart failure patients with personalized health coaching</li> <li><strong class="text-white">Post-discharge follow-up:</strong> Automated patient calls checking medication adherence, symptoms, and recovery progress</li> <li><strong class="text-white">Pre-visit preparation:</strong> Patient interviews gathering symptoms, medical history, and visit objectives before appointments</li> <li><strong class="text-white">Multilingual support:</strong> Conversational AI in 20+ languages addressing health equity gaps</li> </ul> <p class="text-lg text-gray-100 leading-relaxed"> The company has signed pilots with <strong class="text-white">12 health systems</strong> and reports <strong class="text-white">92% patient satisfaction</strong> in early deployments. Hippocratic AI claims its platform can handle tasks currently performed by nurses and medical assistants at <strong class="text-white">1/10th the cost</strong>, potentially addressing healthcare workforce shortages. </p> <p class="text-lg text-gray-100 leading-relaxed"> The funding will accelerate clinical pilots, expand the agent library to 50+ use cases, and build out safety testing infrastructure. The company is pursuing regulatory pathways for specific clinical applications while offering non-regulated administrative functions. </p> <p class="text-sm text-gray-400 mt-6"> Source: Hippocratic AI Press Release, September 2024 | TechCrunch </p> </div>

This briefing summarises publicly available research and reporting for information only. It is not medical, investment, or legal advice. Follow the references above to the primary sources.